You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
What Are My Treatment Options?
QUESTIONS TO ASK YOURSELF
Do you persistently experience any of these:
ear pressure, ear pain, or clogged ears?
If so, treatment with the ACCLARENT AERA® Eustachian Tube Balloon Dilation System may be right for you.
Have you been unresponsive to an intranasal steroid spray or an oral steroid?
Different approaches to the treatment of ETD are available. In one published study, nasal steroids showed no effect on ETD symptoms.1 The ACCLARENT AERA® Eustachian Tube Balloon Dilation System may be a viable alternative treatment for patients with persistent ETD symptoms.
Have you seen a doctor for your ear pain?
If so, ask your doctor about the ACCLARENT AERA® Eustachian Tube Balloon Dilation System. If not, enter your ZIP code to locate a specialist who can assess your symptoms.
1. Randrup TS & Ovesen T. (2015). Balloon Eustachian Tuboplasty: A Systematic Review. Otolaryngol Head Neck Surg. 152(3): 383-392
Indications For Use
The ACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended to dilate the Eustachian tube for treatment of persistent Eustachian tube dysfunction in adults ages 18 and older.
Important Safety Information
Acclarent® Technology is intended for use by or under the direction of a physician. Eustachian tube balloon dilation has associated risks, including tissue and mucosal trauma, infection, or possible carotid artery injury. Consult your physician for a full discussion of risks and benefits to determine whether this procedure is right for you. The success of this procedure depends on many factors, including your physical condition and your body’s ability to tolerate the procedure. Use care in the selection of your doctors and hospital, based on their skill and experience.
Caution: Federal (US) law restricts the sale, distribution or use of these devices to, by or on the order of a physician.
This site is published by Acclarent, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.
© Acclarent, Inc. 2019 Last Updated on 11/19/2019